La catena delle opzioni mostra i dati chiave delle opzioni azionarie di LQR House a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per LQR House..

LQR House (NASDAQ:YHC) Azioni, Catena delle Opzioni

LQR House

LQR House Inc intends to become the full-service digital marketing and brand development face of the alcoholic beverage space. It also intends to integrate the supply, sales, and marketing facets of the alcoholic beverage space into one easy-to-use platform and become the one-stop shop for everything related to alcohol. The company's primary business includes the development of premium limited-batch spirit brands, establishing an exclusive wine club, and marketing internal and external brands through an exclusive agreement with a United States-based e-commerce portal. It believes that the marketing and brand management services it provides to its wholly owned and third-party clients will increase brand recognition, and drive sales thereof through its e-commerce platform partner.

Wall Street

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

IOTR

L&#39;indicatore di forza relativa evidenzia due azioni del settore tecnologico e telecomunicazioni che potrebbero invertire la rotta.

2 titoli sottovalutati pronti al decollo? Ecco di chi si tratta

LQR House Inc

<p><a href="https://www.youtube.com/watch?v=GfPxgLo7lvY">https://www.youtube.com/watch?v=GfPxgLo7lvY</a></p>


Politics

Economics

Federal Reserve

General

Federal Reserve Vice Chair For Supervision Michelle Bowman Says Fed Will Also Be Reconsidering Use Of 'horizontal Reviews' Of Specific Issues At Numerous Banks; Says Fed Will Be Reviewing Wide Range Of Existing Guidance;  Says Fed To Propose Changes To How It Rates Large Banks In Supervision

<p><strong>ABM Industries Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABM#NYSE">ABM</a>) shares are trading higher after the company reported <a href="https://www.benzinga.com/pressreleases/25/06/g45810220/abm-reports-fiscal-second-quarter-2025-results" target="_blank" rel="noreferrer noopener">second-quarter FY25 earnings</a>.</p>
<p>Revenue grew 4.6% year over year (Y/Y) to $2.11 billion, beating the consensus of $2.06 billion. This was led by organic growth of 3.8% and a 0.8% contribution from acquisitions.</p>
<p>Revenue growth was driven by Technical Solutions (+19.3%&nbsp;Y/Y) and Aviation (+9.2%&nbsp;Y/Y), with Business &amp; Industry revenue rising&nbsp;2.6%&nbsp;Y/Y.</p>
<p>ABM CEO <strong>Scott Salmirs</strong> said the company secured $1.1 billion in new bookings through the first half of the year. That&#8217;s an 11% increase year over year. </p>
<p>Operating profit rose&nbsp;1.2%&nbsp;Y/Y to&nbsp;$82.3 million&nbsp;in the quarter. Adjusted EBITDA rose to&nbsp;$125.9 million&nbsp;from&nbsp;$121.0 million&nbsp;a year ago quarter, with the adjusted EBITDA margin stood at&nbsp;6.2% (flat Y/Y).</p>
<p>Adjusted EPS of&nbsp;86 cents was<a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener"> in line with the consensus</a>.</p>
<p>Notably, following discussions with SEC, the company revised its non-GAAP financial measures to include &#8220;prior year self-insurance adjustments&#8221; (net changes to prior claims reserves), which applies to second quarter 2025 results and retroactively to all periods for comparability.</p>
<p>Consequently, the second quarter 2024 results-adjusted financials now show $4.3 million (or $0.05/share) in unfavorable prior-year self-insurance adjustments as corporate costs; the change didn&#8217;t impact&nbsp;&nbsp;second quarter 2025.</p>
<p>Net cash used in operating activities was&nbsp;$32.3&nbsp;million, and free cash flow was $15.2&nbsp;million, primarily reflecting an increase in working capital due to the transition to the new enterprise resource planning (ERP) system.</p>
<p>As of quarter-end, ABM held cash and cash equivalents of&nbsp;$58.7 million.</p>
<p><strong>Dividend</strong>: ABM declared a cash dividend of $0.265 per common share, payable on August 4. Shareholders must be on record as of July 3, 2025.</p>
<p><strong>FY25 Outlook:</strong>&nbsp;ABM reiterated the adjusted EPS&nbsp;outlook&nbsp;at&nbsp;$3.65<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">&nbsp;to&nbsp;$3.80&nbsp;versus the consensus of&nbsp;$3.77</a>.</p>
<p>The company continues to see an adjusted EBITDA margin of&nbsp;6.3%-&nbsp;6.5%.</p>
<p>Salmirs added, "We remain constructive on the outlook for our core markets, particularly high-quality office buildings, manufacturing and distribution facilities, commercial aviation, and microgrids. Further, projects delayed in the second quarter are expected to be realized in the third quarter."</p>
<p>Investors can gain exposure to the stock via&nbsp;<strong>VanEck Environmental Services ETF</strong>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVX#NYSE">EVX</a>) and <strong>Listed Funds Trust Dividend Performers ETF</strong> (BATS:<a class="ticker" href="https://www.benzinga.com/stock/IPDP#BATS">IPDP</a>).</p>
<p><strong>Price Action:</strong>&nbsp;ABM shares are up&nbsp;0.06%&nbsp;at&nbsp;$51.26<strong> </strong>premarket at the last check Friday.</p>
<p><strong>Read Next</strong>:</p>
<ul class="wp-block-list">
<li><strong><a href="https://www.benzinga.com/markets/equities/25/06/45809783/us-stocks-likely-to-open-higher-traders-have-become-jaded-about-trumps-tumultuous-trade-dealmaking-says-expert" target="_blank" rel="noreferrer noopener">US Stocks Likely To Open Higher: &#8216;Traders Have Become Jaded About Trump&#8217;s Tumultuous Trade Dealmaking,&#8217; Says Expert</a></strong></li>
</ul>
<p><em>Image: Shutterstock</em></p>


Earnings

Equities

Mid Cap

Guidance

IPDP

ABM Industries Cleans Up In Q2: Revenue Soars Past Estimates On Tech, Aviation Growth

Federal Reserve Vice Chair For Supervision Michelle Bowman Says  Fed Considering An Independent Supervisory And Regulatory Framework For Community Banks; Says Regulators And Congress Should Reconsider Bank Size Thresholds For Assigning Bank Rules; Says Central Bank Will Review Supervision And Capital Rules For Large And Small Banks;

<p>Macquarie  analyst Steve Koenig   maintains MongoDB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) with a Neutral and raises the price target from $215 to $230.</p>


Price Target

Analyst Ratings

Macquarie Maintains Neutral on MongoDB, Raises Price Target to $230

<p><i>nnounces Notification of Additional Delinquency with Nasdaq for Late Filing of Annual Report on Form 10-K for the period ended December 31, 2024 and its Quarterly Report on Form 10-Q for the period ended</i>&nbsp;<i>March 31, 2025</i></p>
<p><i>Expects to Return to Normal Filing Cadence by Fall 2025</i></p>
<p>LOS ANGELES, June 6, 2025 /PRNewswire/ -- B. Riley Financial, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RILY#NASDAQ">RILY</a>) ("B. Riley" or the "Company"), a diversified financial services company, today announced it received an additional delinquency notification letter from Nasdaq on&nbsp;June 4, 2025, which indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of the delayed filing of the Company's Annual Report on Form 10-K for the period ended December 31, 2024 and its Quarterly Report on Form 10-Q for the period ended March 30, 2025. The Nasdaq Listing Rule requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the "SEC"). This notification has no immediate effect on the listing of the Company's securities on Nasdaq.</p>


RILY

B. Riley Financial Receives Additional Nasdaq Delinquency Notice For Late SEC Filings; Expects To Return To Normal Filing Cadence by Fall 2025

<p>Cantor Fitzgerald  analyst Jonathan Ruykhaver   maintains Rubrik (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBRK#NYSE">RBRK</a>) with a Overweight and raises the price target from $95 to $115.</p>


RBRK

Cantor Fitzgerald Maintains Overweight on Rubrik, Raises Price Target to $115

<p>Skillsoft (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKIL#NYSE">SKIL</a>) will release its quarterly earnings report on Monday, 2025-06-09. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Skillsoft to report an <strong>earnings per share</strong> (EPS) of $-2.65.</p>
<p>Investors in Skillsoft are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Historical Earnings Performance</h3>
<p>In the previous earnings release, the company beat EPS by $4.16, leading to a 22.01% increase in the share price the following trading session.</p>
<p>Here's a look at Skillsoft's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2025</strong></th>
<th><strong>Q3 2025</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-2.05</td>
<td>-3</td>
<td>-2.88</td>
<td>-3.37</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>2.11</td>
<td>-1.82</td>
<td>-2.40</td>
<td>-3.37</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>22.0%</td>
<td>25.0%</td>
<td>-16.0%</td>
<td>12.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1749218521_0.png" alt="eps graph" /></p>
<h3>Skillsoft Share Price Analysis</h3>
<p>Shares of Skillsoft were trading at $18.59 as of June 05. Over the last 52-week period, shares are up 97.02%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/SKIL/earnings"><strong>To track all earnings releases for Skillsoft visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


SKIL

What's Next: Skillsoft's Earnings Preview

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>Trade Desk</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with TTD, it often means somebody knows something is about to happen.</p>
<p>Today, Benzinga's options scanner spotted 15 options trades for <strong>Trade Desk</strong>.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 53% bullish and 40%, bearish.</p>
<p>Out of all of the options we uncovered, there was 1 put, for a total amount of $66,500, and 14, calls, for a total amount of $848,400.</p>
<h3>Predicted Price Range</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $47.5 to $75.0 for Trade Desk over the recent three months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>In today's trading context, the average open interest for options of Trade Desk stands at 904.07, with a total volume reaching 975.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Trade Desk, situated within the strike price corridor from $47.5 to $75.0, throughout the last 30 days.</p>
<h3>Trade Desk 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1749218514_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>TTD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$30.0</td>
<td>$29.35</td>
<td>$30.0</td>
<td>$55.00</td>
<td>$240.0K</td>
<td>891</td>
<td align="right">80</td>
</tr>
<tr>
<td>TTD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$5.4</td>
<td>$5.25</td>
<td>$5.25</td>
<td>$70.00</td>
<td>$131.2K</td>
<td>1.7K</td>
<td align="right">250</td>
</tr>
<tr>
<td>TTD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$6.65</td>
<td>$6.55</td>
<td>$6.65</td>
<td>$75.00</td>
<td>$66.5K</td>
<td>1.1K</td>
<td align="right">101</td>
</tr>
<tr>
<td>TTD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/27/25</td>
<td>$19.9</td>
<td>$19.45</td>
<td>$19.45</td>
<td>$52.00</td>
<td>$58.3K</td>
<td>37</td>
<td align="right">30</td>
</tr>
<tr>
<td>TTD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$19.0</td>
<td>$18.95</td>
<td>$19.0</td>
<td>$60.00</td>
<td>$57.0K</td>
<td>1.6K</td>
<td align="right">30</td>
</tr>
</tbody>
</table>
</p>
<h3>About Trade Desk</h3>
<p>The Trade Desk provides a self-service platform that helps advertisers and ad agencies programmatically find and purchase digital ad inventory (display, video, audio, and social) on devices like computers, smartphones, and connected TVs. It uses data in an iterative manner to optimize the performance of ad impressions purchased. The firm's platform is referred to as a demand-side platform in the digital ad industry, and it generates revenue from fees based on a percentage of what its clients spend on advertising.</p>
<p>Having examined the options trading patterns of Trade Desk, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Where Is Trade Desk Standing Right Now?</h3>
<ul>
<li>With a volume of 941,223, the price of TTD is up 0.06% at $71.15. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 62 days.</li>
</ul>
<h3>What The Experts Say On Trade Desk</h3>
<p>5 market experts have recently issued ratings for this stock, with a consensus target price of $84.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Guggenheim has decided to maintain their Buy rating on Trade Desk, which currently sits at a price target of $90.<br />
&#x2A; An analyst from Rosenblatt has decided to maintain their Buy rating on Trade Desk, which currently sits at a price target of $78.<br />
&#x2A; An analyst from Needham has revised its rating downward to Buy, adjusting the price target to $84.<br />
&#x2A; In a cautious move, an analyst from Needham downgraded its rating to Buy, setting a price target of $84.<br />
&#x2A; An analyst from Needham has revised its rating downward to Buy, adjusting the price target to $84. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Trade Desk with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


Options

Trade Desk Unusual Options Activity

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>UnitedHealth Group</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with UNH, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 16 uncommon options trades for UnitedHealth Group.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 50% bullish and 37%, bearish.</p>
<p>Out of all of the special options we uncovered, 4 are puts, for a total amount of $399,938, and 12 are calls, for a total amount of $941,035.</p>
<h3>What's The Price Target?</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $240.0 and $550.0 for UnitedHealth Group, spanning the last three months.</p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for UnitedHealth Group's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across UnitedHealth Group's significant trades, within a strike price range of $240.0 to $550.0, over the past month.</p>
<h3>UnitedHealth Group Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1749218509_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>UNH</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$23.5</td>
<td>$22.85</td>
<td>$23.5</td>
<td>$320.00</td>
<td>$235.0K</td>
<td>4.9K</td>
<td align="right">201</td>
</tr>
<tr>
<td>UNH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/17/27</td>
<td>$75.5</td>
<td>$73.6</td>
<td>$73.6</td>
<td>$300.00</td>
<td>$220.8K</td>
<td>2.9K</td>
<td align="right">32</td>
</tr>
<tr>
<td>UNH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$15.5</td>
<td>$15.3</td>
<td>$15.3</td>
<td>$300.00</td>
<td>$153.0K</td>
<td>3.9K</td>
<td align="right">176</td>
</tr>
<tr>
<td>UNH</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$23.5</td>
<td>$18.7</td>
<td>$20.43</td>
<td>$290.00</td>
<td>$114.4K</td>
<td>1.1K</td>
<td align="right">0</td>
</tr>
<tr>
<td>UNH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$19.8</td>
<td>$19.55</td>
<td>$19.57</td>
<td>$290.00</td>
<td>$113.4K</td>
<td>1.2K</td>
<td align="right">73</td>
</tr>
</tbody>
</table>
</p>
<h3>About UnitedHealth Group</h3>
<p>UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.</p>
<p>Having examined the options trading patterns of UnitedHealth Group, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Where Is UnitedHealth Group Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 1,692,308, with UNH's price up by 1.39%, positioned at $299.94.</li>
<li>RSI indicators show the stock to be may be approaching oversold.</li>
<li>Earnings announcement expected in 39 days.</li>
</ul>
<h3>Professional Analyst Ratings for UnitedHealth Group</h3>
<p>In the last month, 5 experts released ratings on this stock with an average target price of $364.2.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from B of A Securities has revised its rating downward to Neutral, adjusting the price target to $350.<br />
&#x2A; Consistent in their evaluation, an analyst from Piper Sandler keeps a Overweight rating on UnitedHealth Group with a target price of $353.<br />
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on UnitedHealth Group, which currently sits at a price target of $351.<br />
&#x2A; An analyst from JP Morgan has decided to maintain their Overweight rating on UnitedHealth Group, which currently sits at a price target of $405.<br />
&#x2A; An analyst from Barclays persists with their Overweight rating on UnitedHealth Group, maintaining a target price of $362. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for UnitedHealth Group with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


Decoding UnitedHealth Group's Options Activity: What's the Big Picture?

<p>Motorcar Parts of America (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MPAA#NASDAQ">MPAA</a>) is preparing to release its quarterly earnings on Monday, 2025-06-09. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Motorcar Parts of America to report an <strong>earnings per share</strong> (EPS) of $0.20.</p>
<p>The market awaits Motorcar Parts of America's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Performance in Previous Earnings</h3>
<p>Last quarter the company missed EPS by $0.08, which was followed by a 6.76% increase in the share price the next day.</p>
<p>Here's a look at Motorcar Parts of America's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2025</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.43</td>
<td>0</td>
<td>0.07</td>
<td>0.16</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.35</td>
<td>0.31</td>
<td>-0.33</td>
<td>0.06</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>7.000000000000001%</td>
<td>1.0%</td>
<td>1.0%</td>
<td>6.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1749218508_0.png" alt="eps graph" /></p>
<h3>Motorcar Parts of America Share Price Analysis</h3>
<p>Shares of Motorcar Parts of America were trading at $11.85 as of June 05. Over the last 52-week period, shares are up 129.33%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/MPAA/earnings"><strong>To track all earnings releases for Motorcar Parts of America visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


MPAA

Earnings Preview For Motorcar Parts of America

RXRX

Recursion Highlights Release With MIT Of Boltz-2: Next Generation AI Model

<p>Deep-pocketed investors have adopted a bullish approach towards Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in ORCL usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 10 extraordinary options activities for Oracle. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 50% leaning bullish and 0% bearish. Among these notable options, 2 are puts, totaling $77,100, and 8 are calls, amounting to $409,394.</p>
<h3>What's The Price Target?</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $147.0 to $180.0 for Oracle over the last 3 months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>In today's trading context, the average open interest for options of Oracle stands at 2104.67, with a total volume reaching 546.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Oracle, situated within the strike price corridor from $147.0 to $180.0, throughout the last 30 days.</p>
<h3>Oracle 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1749218505_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>ORCL</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$13.6</td>
<td>$12.3</td>
<td>$12.89</td>
<td>$165.00</td>
<td>$123.7K</td>
<td>7.2K</td>
<td align="right">7</td>
</tr>
<tr>
<td>ORCL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/13/25</td>
<td>$27.25</td>
<td>$25.65</td>
<td>$27.25</td>
<td>$147.00</td>
<td>$81.7K</td>
<td>15</td>
<td align="right">0</td>
</tr>
<tr>
<td>ORCL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$8.9</td>
<td>$8.45</td>
<td>$8.45</td>
<td>$175.00</td>
<td>$50.6K</td>
<td>1.3K</td>
<td align="right">65</td>
</tr>
<tr>
<td>ORCL</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/13/25</td>
<td>$4.65</td>
<td>$4.1</td>
<td>$4.38</td>
<td>$180.00</td>
<td>$42.0K</td>
<td>2.5K</td>
<td align="right">99</td>
</tr>
<tr>
<td>ORCL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>06/13/25</td>
<td>$6.65</td>
<td>$6.45</td>
<td>$6.52</td>
<td>$175.00</td>
<td>$39.1K</td>
<td>871</td>
<td align="right">207</td>
</tr>
</tbody>
</table>
</p>
<h3>About Oracle</h3>
<p>Oracle provides enterprise applications and infrastructure offerings around the world through a variety of flexible IT deployment models, including on-premises, cloud-based, and hybrid. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system, which is commonly used for running online transaction processing and data warehousing workloads. Besides database systems, Oracle also sells enterprise resource planning, or ERP, customer relationship management, or CRM, and human capital management, or HCM, applications. Today, Oracle has more than 159,000 full-time employees in over 170 countries.</p>
<p>In light of the recent options history for Oracle, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Present Market Standing of Oracle</h3>
<ul>
<li>Trading volume stands at 547,561, with ORCL's price up by 1.53%, positioned at $173.76.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 5 days.</li>
</ul>
<h3>What Analysts Are Saying About Oracle</h3>
<p>A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $220.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Guggenheim has revised its rating downward to Buy, adjusting the price target to $220. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Oracle with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


ORCL

Smart Money Is Betting Big In ORCL Options

<p>Despite better-than-expected <a href="https://www.benzinga.com/markets/equities/25/06/45810084/lululemon-stock-crashes-nearly-21-in-friday-pre-market-whats-going-on">first quarter results</a>, <strong>Lululemon Athletica Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>)&#8217;s management cautioned that the second quarter will bear the brunt of increased tariffs and lowered its full year earnings per share forecast.</p>
<p><strong>What Happened: </strong>CFO <strong>Meghan Frank</strong> outlined the company&#8217;s financial outlook during its earnings call, highlighting that the gross margin in the second quarter is expected to decline by approximately 200 basis points relative to the same quarter of the previous fiscal year.</p>
<p>This notable dip is primarily attributed to higher tariff rates, alongside increased occupancy and depreciation costs, modestly higher markdowns and foreign exchange impacts.</p>
<p>&#8220;We are planning to take strategic price increases, looking item by item across our assortment as we typically do, and it will be price increases on a small portion of our assortment, and they will be modest in nature,&#8221; said CFO Frank.</p>
<p>These price increases are expected to begin rolling out toward the latter half of the second quarter and into the third quarter.</p>
<p>Furthermore, the company lowered its full-year earnings forecast to $14.58 to $14.78 per share, down from prior guidance of $14.95 to $15.15 per share.</p>
<p><strong>Garly Black,</strong> the managing partner at Future Fund LLC, said that the EPS miss was a result of competition. &#8220;We see this as a result of intense competitive conditions rather than macro challenges,&#8221; he said.</p>
<p><figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><p lang="en" dir="ltr"><a href="https://twitter.com/search?q=%24LULU&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$LULU</a> (-16% AH, no position) guided to 2Q rev and eps forecasts that badly missed WS estimates.   We see this as a result of intense competitive conditions rather than macro challenges. <br /><br />1Q actual:<br />&#8211; Revs $2.37B vs $2.36B est<br />&#8211; Adj EPS $2.60 vs $2.60 est<br />&#8211; SSS ex-FX +1.0% vs…</p>
<p>&mdash; Gary Black (@garyblack00) <a href="https://twitter.com/garyblack00/status/1930724071232209054?ref_src=twsrc%5Etfw">June 5, 2025</a></p></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<p></p></figure></p>
<p><strong>See Also:<a href="https://www.benzinga.com/markets/market-summary/25/06/45809203/investors-pay-the-price-as-musk-trump-war-of-words-escalates-once-allies-now-foes-their-linked-stocks-crypto-and-funds-wipe-out-155-billion-in-a-single-day"> Investors Pay The Price As Musk-Trump War Of Words Escalates: Once Allies, Now Foes, Their Linked Stocks, Crypto And Funds Wipe Out $155 Billion In A Single Day</a></strong></p>
<p><strong>Why It Matters:</strong> Lululemon&#8217;s tariff assumptions include a significant 30% incremental tariff on goods sourced from China and an additional 10% on products from other sourcing countries.</p>
<p>To counteract these rising costs, the company is implementing a multi-pronged mitigation strategy, with the most impactful results anticipated in the second half of 2025.</p>
<p>The company reported <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45803189/lululemon-q1-earnings-revenue-beat-eps-in-line-shares-tumble-on-weaker-earnings-forecast">first-quarter revenue</a> of $2.37 billion, beating the&nbsp;consensus estimate&nbsp;of $2.36 billion and earnings of $2.60 per share, in line with analyst estimates.</p>
<p>Apart from the EPS forecast, it expects full-year 2025 revenue to be in the range of $11.15 billion to $11.3 billion versus estimates of $11.24 billion.</p>
<p>LULU shares were down 20.04% in premarket on Friday; they have declined by 11.15% on a year-to-date basis, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.</p>
<p><strong>Benzinga Edge Stock Rankings</strong> show that LULU had a weaker price trend over the short, medium, and long term. Its momentum ranking was moderate, and its value ranking was also moderate at the 49.83th percentile. The details of other metrics are <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">available here</a>. </p>
<p><figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="1024" height="151" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06075738/LULU-EDGE-1024x151.png" alt="" class="wp-image-941117" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06075738/LULU-EDGE-1024x151.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06075738/LULU-EDGE-300x44.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06075738/LULU-EDGE-768x113.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/06075738/LULU-EDGE.png 1158w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure></p>
<p>The <strong>SPDR S&amp;P 500 ETF Trust</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and<strong> Invesco QQQ Trust ETF</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, rose in premarket on Friday. The SPY was up 0.40% at $595.44, while the QQQ advanced 0.44% to $527.08, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.</p>
<p><strong>Read Next:</strong></p>
<ul class="wp-block-list">
<li><strong><a href="https://www.benzinga.com/markets/equities/25/06/45764818/bill-ackman-urges-end-to-fannie-mae-freddie-mac-conservatorship-says-will-enable-them-to-operate-more-successfully-and-efficiently" target="_blank" rel="noreferrer noopener">Bill Ackman Urges End To Fannie Mae, Freddie Mac Conservatorship: Says Will Enable Them To ‘Operate More Successfully And Efficiently&#8217;</a></strong></li>
</ul>


LULU

LULU Stock Under Pressure As Company Warns Q2 Will Feel Tariff Heat, Plans 'Strategic Price Increases' — But Gary Black Blames EPS Revision On 'Competition,' Not 'Macro Challenges'

<p>Graham (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GHM#NYSE">GHM</a>) will release its quarterly earnings report on Monday, 2025-06-09. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Graham to report an <strong>earnings per share</strong> (EPS) of $0.19.</p>
<p>The market awaits Graham's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Overview of Past Earnings</h3>
<p>The company's EPS beat by $0.10 in the last quarter, leading to a 0.0% drop in the share price on the following day.</p>
<p>Here's a look at Graham's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2025</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.08</td>
<td>0.14</td>
<td>0.15</td>
<td>0.04</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.18</td>
<td>0.31</td>
<td>0.33</td>
<td>0.15</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-16.0%</td>
<td>17.0%</td>
<td>3.0%</td>
<td>6.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1749218499_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of Graham were trading at $41.25 as of June 05. Over the last 52-week period, shares are up 44.07%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/GHM/earnings"><strong>To track all earnings releases for Graham visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


What to Expect from Graham's Earnings

<p>Invitation Homes (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INVH#NYSE">INVH</a>) has been analyzed by 11 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.</p>
<p>In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">2</td>
<td align="right">6</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $38.23, a high estimate of $43.00, and a low estimate of $36.00. This upward trend is evident, with the current average reflecting a 4.6% increase from the previous average price target of $36.55.</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1749218491_0.png" alt="price target chart" /></p>
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive Invitation Homes. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Eric Wolfe</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$38.50</td>
<td>$35.00</td>
</tr>
<tr>
<td>Nicholas Yulico</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$38.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Buck Horne</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Outperform</td>
<td>$39.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Richard Hightower</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$39.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Julien Blouin</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$43.00</td>
<td>$39.00</td>
</tr>
<tr>
<td>Tyler Batory</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$41.00</td>
<td>$39.00</td>
</tr>
<tr>
<td>Jade Rahmani</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$37.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Brad Heffern</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$36.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Buck Horne</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$36.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Haendel St. Juste</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$36.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Richard Hightower</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$37.00</td>
<td>$36.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Invitation Homes. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Invitation Homes compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts navigate through adjustments in price targets, providing estimates for Invitation Homes's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Invitation Homes's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/INVH/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Invitation Homes analyst ratings.</strong></a></p>
<h2>Delving into Invitation Homes's Background</h2>
<p>Invitation Homes owns a portfolio of over 85,000 single-family rental homes. The company focuses on owning homes in the starter and move-up segments of the housing market with an average sale price around $350,000 and generally less than 1,800 square feet. The portfolio is spread across 16 target markets that feature high employment and household formation growth with almost 70% of the portfolio in the Western U.S. and Florida; 15 of the 16 markets featuring average rents lower than homeownership costs.</p>
<h3>Invitation Homes's Economic Impact: An Analysis</h3>
<p><strong>Market Capitalization:</strong> Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Invitation Homes's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>4.4%</strong> as of 31 March, 2025, showcasing a substantial increase in top-line earnings. When compared to others in the Real Estate sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>24.54%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Invitation Homes's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>1.7%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Invitation Homes's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>0.89%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Invitation Homes's debt-to-equity ratio is below the industry average at <strong>0.83</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


INVH

Assessing Invitation Homes: Insights From 11 Financial Analysts

<p>VinFast Auto (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFS#NASDAQ">VFS</a>) is gearing up to announce its quarterly earnings on Monday, 2025-06-09. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that VinFast Auto will report an <strong>earnings per share</strong> (EPS) of $-0.26.</p>
<p>The market awaits VinFast Auto's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Earnings History Snapshot</h3>
<p>During the last quarter, the company reported an EPS missed by $0.31, leading to a 2.41% drop in the share price on the subsequent day.</p>
<p>Here's a look at VinFast Auto's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.23</td>
<td>-0.23</td>
<td>-0.21</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.54</td>
<td>-0.23</td>
<td>-0.33</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-2.0%</td>
<td>8.0%</td>
<td>-8.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1749218483_0.png" alt="eps graph" /></p>
<h3>Performance of VinFast Auto Shares</h3>
<p>Shares of VinFast Auto were trading at $3.43 as of June 05. Over the last 52-week period, shares are down 13.6%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/VFS/earnings"><strong>To track all earnings releases for VinFast Auto visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


VinFast Auto's Earnings Outlook

<p>In the preceding three months, 20 analysts have released ratings for Darden Restaurants (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>), presenting a wide array of perspectives from bullish to bearish.</p>
<p>The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">6</td>
<td align="right">6</td>
<td align="right">8</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">6</td>
<td align="right">5</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts have recently evaluated Darden Restaurants and provided 12-month price targets. The average target is $210.8, accompanied by a high estimate of $238.00 and a low estimate of $175.00. Observing a 4.56% increase, the current average has risen from the previous average price target of $201.60. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1749218475_0.png" alt="price target chart" /></p>
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
<p>A clear picture of Darden Restaurants's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Eric Gonzalez</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$230.00</td>
<td>$220.00</td>
</tr>
<tr>
<td>David Tarantino</td>
<td>Baird</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$192.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Greg Francfort</td>
<td>Guggenheim</td>
<td>Raises</td>
<td>Buy</td>
<td>$220.00</td>
<td>$205.00</td>
</tr>
<tr>
<td>Zachary Fadem</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$200.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>Jon Tower</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$229.00</td>
<td>$223.00</td>
</tr>
<tr>
<td>Jeffrey Bernstein</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$235.00</td>
<td>$230.00</td>
</tr>
<tr>
<td>Brian Harbour</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$217.00</td>
<td>$209.00</td>
</tr>
<tr>
<td>Andrew Strelzik</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$190.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>Eric Gonzalez</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$220.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Dennis Geiger</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$225.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Brian Bittner</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$230.00</td>
<td>$218.00</td>
</tr>
<tr>
<td>David Tarantino</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$210.00</td>
<td>$192.00</td>
</tr>
<tr>
<td>Jim Salera</td>
<td>Stephens &amp; Co.</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$178.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>Chris O'Cull</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$215.00</td>
<td>$205.00</td>
</tr>
<tr>
<td>Sara Senatore</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$238.00</td>
<td>$230.00</td>
</tr>
<tr>
<td>Nick Setyan</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Outperform</td>
<td>$235.00</td>
<td>$220.00</td>
</tr>
<tr>
<td>Andrew Charles</td>
<td>TD Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$190.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>Jim Salera</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$175.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>Jake Bartlett</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$212.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Jim Salera</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$175.00</td>
<td>$175.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Darden Restaurants. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Darden Restaurants compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts predict movements in price targets, offering estimates for Darden Restaurants's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Darden Restaurants's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/DRI/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Darden Restaurants analyst ratings.</strong></a></p>
<h2>About Darden Restaurants</h2>
<p>Darden Restaurants is the largest restaurant operator in the US full-service space, with consolidated revenue of $11.4 billion in fiscal 2024 resulting in 3%-4% full-service market share (per NRA data and our calculations). The company maintains a portfolio of 11 restaurant brands: Olive Garden, LongHorn Steakhouse, Cheddar's Scratch Kitchen, Ruth's Chris, Yard House, The Capital Grille, Seasons 52, Eddie V's, Bahama Breeze, The Capital Burger, and most recently, Chuy's. Darden generates revenue almost exclusively from company-owned restaurants, though a small network of franchised restaurants and consumer-packaged goods sales through the traditional grocery channel contribute modestly. As of the end of its fiscal 2024, the company operated 2,031 restaurants in the US.</p>
<h3>Darden Restaurants: Financial Performance Dissected</h3>
<p><strong>Market Capitalization Analysis:</strong> With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.</p>
<p><strong>Revenue Growth:</strong> Darden Restaurants displayed positive results in 3M. As of 28 February, 2025, the company achieved a solid revenue growth rate of approximately <strong>6.16%</strong>. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Discretionary sector.</p>
<p><strong>Net Margin:</strong> Darden Restaurants's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>10.24%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Darden Restaurants's ROE excels beyond industry benchmarks, reaching <strong>15.13%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Darden Restaurants's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>2.58%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>2.76</strong>.</p>
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


20 Analysts Assess Darden Restaurants: What You Need To Know

<p>Lakeland Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAKE#NASDAQ">LAKE</a>) will release its quarterly earnings report on Monday, 2025-06-09. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Lakeland Industries to report an <strong>earnings per share</strong> (EPS) of $0.22.</p>
<p>The market awaits Lakeland Industries's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<p>Here's a look at Lakeland Industries's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2025</strong></th>
<th><strong>Q3 2025</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td></td>
<td>0.40</td>
<td>0.35</td>
<td>0.31</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.03</td>
<td>0.01</td>
<td>-0.19</td>
<td>0.38</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-14.000000000000002%</td>
<td>2.0%</td>
<td>-8.0%</td>
<td>9.0%</td>
</tr>
</tbody>
</table>
</p>
<h3>Market Performance of Lakeland Industries's Stock</h3>
<p>Shares of Lakeland Industries were trading at $18.45 as of June 05. Over the last 52-week period, shares are down 17.96%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. </p>
<h3>Analyst Insights on Lakeland Industries</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Lakeland Industries.</p>
<p>The consensus rating for Lakeland Industries is Buy, based on 3 analyst ratings. With an average one-year price target of $27.0, there's a potential 46.34% upside.</p>
<h3>Peer Ratings Comparison</h3>
<p>The following analysis focuses on the analyst ratings and average 1-year price targets of Superior Gr of Cos, Vera Bradley and Movado Group, three prominent industry players, providing insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Outperform trajectory for Superior Gr of Cos, with an average 1-year price target of $17.25, suggesting a potential 6.5% downside.</li>
<li>Analysts currently favor an Buy trajectory for Vera Bradley, with an average 1-year price target of $4.0, suggesting a potential 78.32% downside.</li>
<li>Analysts currently favor an Buy trajectory for Movado Group, with an average 1-year price target of $31.5, suggesting a potential 70.73% upside.</li>
</ul>
<h3>Analysis Summary for Peers</h3>
<p>The peer analysis summary offers a detailed examination of key metrics for Superior Gr of Cos, Vera Bradley and Movado Group, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lakeland Industries</td>
<td>Buy</td>
<td>49.26%</td>
<td>$18.69M</td>
<td>-13.59%</td>
</tr>
<tr>
<td>Superior Gr of Cos</td>
<td>Outperform</td>
<td>-1.26%</td>
<td>$50.44M</td>
<td>-0.39%</td>
</tr>
<tr>
<td>Vera Bradley</td>
<td>Buy</td>
<td>-24.99%</td>
<td>$44.96M</td>
<td>-23.25%</td>
</tr>
<tr>
<td>Movado Group</td>
<td>Buy</td>
<td>-1.94%</td>
<td>$71.35M</td>
<td>0.29%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Lakeland Industries ranks at the bottom for Revenue Growth and Gross Profit among its peers. It is in the middle for Consensus and Return on Equity.</p>
<h3>Unveiling the Story Behind Lakeland Industries</h3>
<p>Lakeland Industries Inc manufactures and sells safety garments and accessories for the industrial protective clothing market. Its product segments include Disposables, Chemicals, Fire, Gloves, High Visibility, High-Performance Wear, and Wovens. Its customers include integrated oil, chemical/petrochemical, utilities, automobile, steel, glass, construction, smelting, munition plants, janitorial, pharmaceutical, and mortuaries, as well as scientific and medical laboratories. Its geographical segments include the United States, Latin America, Canada, Asia, Mexico, Europe (United Kingdom), and Other Foreign.</p>
<h3>Lakeland Industries: Delving into Financials</h3>
<p><strong>Market Capitalization Analysis:</strong> The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Lakeland Industries's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>49.26%</strong> as of 31 January, 2025, showcasing a substantial increase in top-line earnings. When compared to others in the Consumer Discretionary sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> Lakeland Industries's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of <strong>-39.54%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Lakeland Industries's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of <strong>-13.59%,</strong> the company may encounter challenges in delivering satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>-8.91%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.22</strong>.</p>
<p><a href="https://www.benzinga.com/quote/LAKE/earnings"><strong>To track all earnings releases for Lakeland Industries visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


LAKE

Exploring Lakeland Industries's Earnings Expectations

<p>Analysts' ratings for Fastly (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSLY#NYSE">FSLY</a>) over the last quarter vary from bullish to bearish, as provided by 5 analysts.</p>
<p>In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $6.8, with a high estimate of $8.00 and a low estimate of $6.00. A 2.86% drop is evident in the current average compared to the previous average price target of $7.00. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1749218456_0.png" alt="price target chart" /></p>
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
<p>The standing of Fastly among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Rishi Jaluria</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$6.00</td>
<td>$5.00</td>
</tr>
<tr>
<td>James Fish</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$7.00</td>
<td>$6.00</td>
</tr>
<tr>
<td>Sanjit Singh</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$8.00</td>
<td>$7.00</td>
</tr>
<tr>
<td>Sanjit Singh</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$7.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>James Fish</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$6.00</td>
<td>$9.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Fastly. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Fastly compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts navigate through adjustments in price targets, providing estimates for Fastly's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>For valuable insights into Fastly's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/FSLY/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Fastly analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.</p>
<h2>Delving into Fastly's Background</h2>
<p>Fastly operates a content delivery network, which is necessary for entities to provide faster and more reliable online content. Fastly's strategy differs from traditional CDNs, which focus on locating servers in as many locations as possible to store copies of files that consumers most use. Fastly is in far fewer sites than traditional CDNs, but it houses servers in the most network-dense data centers. Instead of simply storing static content, it allows its customers to program on its platform, enabling edge computing and better service of the more dynamic content that was traditionally not well served by CDNs. Fastly gears its service to the largest, most sophisticated enterprises rather than small companies and generated nearly three fourths of its revenue in the United States in 2024.</p>
<h3>Fastly: A Financial Overview</h3>
<p><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Fastly displayed positive results in 3M. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately <strong>8.2%</strong>. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.</p>
<p><strong>Net Margin:</strong> Fastly's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of <strong>-27.1%,</strong> the company may encounter challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of <strong>-4.07%,</strong> the company may need to address challenges in generating satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Fastly's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of <strong>-2.7%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.42</strong>, Fastly adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<h2>How Are Analyst Ratings Determined?</h2>
<p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<p>Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


FSLY

What 5 Analyst Ratings Have To Say About Fastly

<p>Providing a diverse range of perspectives from bullish to bearish, 28 analysts have published ratings on Sarepta Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>) in the last three months.</p>
<p>Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">5</td>
<td align="right">12</td>
<td align="right">10</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">3</td>
<td align="right">6</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
<p>Analysts have recently evaluated Sarepta Therapeutics and provided 12-month price targets. The average target is $102.54, accompanied by a high estimate of $202.00 and a low estimate of $40.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 22.03%. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1749218448_0.png" alt="price target chart" /></p>
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
<p>The standing of Sarepta Therapeutics among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Louise Chen</td>
<td>Scotiabank</td>
<td>Maintains</td>
<td>Sector Outperform</td>
<td>$80.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Raghuram Selvaraju</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$40.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Anupam Rama</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$84.00</td>
<td>$169.00</td>
</tr>
<tr>
<td>Yanan Zhu</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$100.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Brian Abrahams</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$58.00</td>
<td>$87.00</td>
</tr>
<tr>
<td>Salveen Richter</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Buy</td>
<td>$100.00</td>
<td>$178.00</td>
</tr>
<tr>
<td>Debjit Chattopadhyay</td>
<td>Guggenheim</td>
<td>Lowers</td>
<td>Buy</td>
<td>$98.00</td>
<td>$112.00</td>
</tr>
<tr>
<td>Biren Amin</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$70.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Hartaj Singh</td>
<td>Oppenheimer</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$123.00</td>
<td>$184.00</td>
</tr>
<tr>
<td>Kristen Kluska</td>
<td>Cantor Fitzgerald</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$81.00</td>
<td>$163.00</td>
</tr>
<tr>
<td>Mitchell Kapoor</td>
<td>HC Wainwright &amp; Co.</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$40.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Matthew Harrison</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$113.00</td>
<td>$182.00</td>
</tr>
<tr>
<td>Gil Blum</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$125.00</td>
<td>$183.00</td>
</tr>
<tr>
<td>Biren Amin</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$110.00</td>
<td>$182.00</td>
</tr>
<tr>
<td>Mitchell Kapoor</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$75.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Matthew Harrison</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$182.00</td>
<td>$196.00</td>
</tr>
<tr>
<td>Yanan Zhu</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Overweight</td>
<td>$115.00</td>
<td>-</td>
</tr>
<tr>
<td>Mitchell Kapoor</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$75.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Mitchell Kapoor</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$75.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Gil Blum</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$183.00</td>
<td>$202.00</td>
</tr>
<tr>
<td>Mitchell Kapoor</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$75.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Brian Abrahams</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$87.00</td>
<td>$161.00</td>
</tr>
<tr>
<td>Louise Chen</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$80.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Kristen Kluska</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$163.00</td>
<td>$163.00</td>
</tr>
<tr>
<td>Mitchell Kapoor</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Sell</td>
<td>$75.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>David Hoang</td>
<td>Deutsche Bank</td>
<td>Lowers</td>
<td>Hold</td>
<td>$99.00</td>
<td>$124.00</td>
</tr>
<tr>
<td>Gil Blum</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$202.00</td>
<td>$202.00</td>
</tr>
<tr>
<td>Kristen Kluska</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$163.00</td>
<td>$163.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Sarepta Therapeutics. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Sarepta Therapeutics compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts provide insights into price targets, offering estimates for the future value of Sarepta Therapeutics's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Sarepta Therapeutics's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/SRPT/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Sarepta Therapeutics analyst ratings.</strong></a></p>
<h2>Delving into Sarepta Therapeutics's Background</h2>
<p>Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.</p>
<h3>Sarepta Therapeutics: Delving into Financials</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> Sarepta Therapeutics's remarkable performance in 3M is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of <strong>80.15%</strong>. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Health Care sector.</p>
<p><strong>Net Margin:</strong> Sarepta Therapeutics's net margin is impressive, surpassing industry averages. With a net margin of <strong>-60.08%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of <strong>-33.52%,</strong> the company may need to address challenges in generating satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Sarepta Therapeutics's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of <strong>-12.05%,</strong> the company may encounter challenges in delivering satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> Sarepta Therapeutics's debt-to-equity ratio is notably higher than the industry average. With a ratio of <b>1.18</b>, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<p>Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


SRPT

Sarepta Therapeutics Stock: A Deep Dive Into Analyst Perspectives (28 Ratings)

Press Releases

LQR House Inc. Maintains Steady Year-Over-Year Revenue Despite Eliminating Paid Advertising, Showcasing SEO Strength While Advancing Profitability Strategy

LQR House Reports 118.67% Month-Over-Month Revenue Growth in February 2025 Compared to January 2025, Achieves 63.82% Year-Over-Year Revenue Increase in February 2025 Compared to February 2024 With $0 Spent on Paid Advertising

Comments

LQR House

LQR House (YHC) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO